Song Xu

2.3k total citations
94 papers, 1.4k citations indexed

About

Song Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Song Xu has authored 94 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 40 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Song Xu's work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Diagnosis and Treatment (16 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Song Xu is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Diagnosis and Treatment (16 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Song Xu collaborates with scholars based in China, Belgium and United Kingdom. Song Xu's co-authors include Karin Vanderkerken, Ivan Van Riet, Ann De Becker, Jun Chen, Ben Van Camp, Kim De Veirman, Eline Menu, Renwang Liu, Xavier Leleu and Sen Wei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Song Xu

88 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Song Xu China 20 580 501 421 400 192 94 1.4k
Flavio Fazioli Italy 18 370 0.6× 558 1.1× 389 0.9× 360 0.9× 122 0.6× 60 1.3k
Dominic Fong Austria 21 645 1.1× 916 1.8× 239 0.6× 254 0.6× 117 0.6× 33 1.7k
Michaela Nathrath Germany 24 689 1.2× 647 1.3× 591 1.4× 392 1.0× 150 0.8× 70 1.8k
Julian Schardt Switzerland 13 468 0.8× 369 0.7× 114 0.3× 392 1.0× 178 0.9× 26 1.1k
Natacha Entz‐Werlé France 19 588 1.0× 428 0.9× 441 1.0× 426 1.1× 61 0.3× 83 1.5k
Rajesh R. Singh United States 15 590 1.0× 366 0.7× 144 0.3× 237 0.6× 192 1.0× 24 1.1k
Joan Somja Belgium 21 452 0.8× 542 1.1× 199 0.5× 204 0.5× 129 0.7× 56 1.5k
Robert Königsberg Austria 16 536 0.9× 676 1.3× 165 0.4× 357 0.9× 365 1.9× 31 1.5k
Susanna Cappia Italy 24 651 1.1× 766 1.5× 748 1.8× 363 0.9× 120 0.6× 56 2.0k
Karl Götte Germany 20 340 0.6× 425 0.8× 257 0.6× 232 0.6× 50 0.3× 44 1.1k

Countries citing papers authored by Song Xu

Since Specialization
Citations

This map shows the geographic impact of Song Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Song Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Song Xu more than expected).

Fields of papers citing papers by Song Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Song Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Song Xu. The network helps show where Song Xu may publish in the future.

Co-authorship network of co-authors of Song Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Song Xu. A scholar is included among the top collaborators of Song Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Song Xu. Song Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Song, et al.. (2024). Prevotellaceae Modulates Colorectal Cancer Immune Microenvironment to Assist Anti-PD-L1 Immunotherapy. The Turkish Journal of Gastroenterology. 35(12). 909–921. 1 indexed citations
2.
Xu, Song, et al.. (2024). Prognosis of unresected versus resected early‐stage pulmonary carcinoid tumors ≤3 cm in size: A population‐based study. Cancer Medicine. 13(11). e7311–e7311. 3 indexed citations
3.
Wu, Yingnan, Jing Zhao, Shuang Zhang, et al.. (2024). Development and validation of a deep learning pipeline to diagnose ovarian masses using ultrasound screening: a retrospective multicenter study. EClinicalMedicine. 78. 102923–102923. 1 indexed citations
4.
Li, Tong, et al.. (2024). Response of a Novel KANK1::ALK Fusion to Alectinib in an Advanced Lung Adenocarcinoma: A Case Report. Journal of the National Comprehensive Cancer Network. 22(2).
5.
Li, Tong, et al.. (2023). Lobe‐specific analysis of perioperative chemotherapy for non‐small cell lung cancer patients. Cancer Medicine. 12(16). 16896–16905. 1 indexed citations
6.
Liu, Minghui, Hongbing Zhang, Jinghao Liu, et al.. (2023). Apatinib added when NSCLC patients get slow progression with EGFR‐TKI: A prospective, single‐arm study. Cancer Medicine. 12(24). 21735–21741. 3 indexed citations
7.
Xu, Song, et al.. (2023). EP12.02-01 Novel-Acquired KANK1-ALK Fusion in An Advanced Lung Adenocarcinoma Responds to Alectinib: A Case Report. Journal of Thoracic Oncology. 18(11). S673–S674.
8.
Li, Tong, Jie Shi, Longlong Wang, et al.. (2023). Thymol targeting interleukin 4 induced 1 expression reshapes the immune microenvironment to sensitize the immunotherapy in lung adenocarcinoma. SHILAP Revista de lepidopterología. 4(5). e355–e355. 11 indexed citations
9.
Zu, Lingling, Ning Zhou, Yifang Zhu, et al.. (2022). The Profile and Clinical Significance of ITGB2 Expression in Non-Small-Cell Lung Cancer. Journal of Clinical Medicine. 11(21). 6421–6421. 19 indexed citations
10.
Zhou, Ning, Tong Li, Bo Zhang, et al.. (2022). Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm. Cancers. 14(13). 3265–3265. 3 indexed citations
11.
Zhou, Ning, Bo Zhang, Shuai Zhu, et al.. (2022). Lobectomy versus sublobar resection for stage I (T1‐T2aN0M0) small cell lung cancer: A SEER population‐based propensity score matching analysis. Cancer Medicine. 12(7). 7923–7931. 4 indexed citations
12.
Zu, Lingling, Xuebing Li, Ning Zhou, et al.. (2022). Establishment and characterization of a novel highly malignant lung cancer cell line ZX2021H derived from a metastatic lymph node lesion. Thoracic Cancer. 13(8). 1199–1210. 2 indexed citations
13.
Zhu, Guangsheng, Hua Huang, Ruifeng Shi, et al.. (2021). Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma. Thoracic Cancer. 12(12). 1890–1899. 15 indexed citations
14.
Wang, Dan, Jun Wang, Dian Ren, et al.. (2021). Primary ciliated muconodular papillary tumor: A rare pulmonary disease and literature review of 65 cases. Thoracic Cancer. 12(12). 1917–1922. 14 indexed citations
15.
He, Xiaoning, Jing Wu, Song Xu, et al.. (2021). Differences in Lung Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Semi-Structured Qualitative Study in China. Patient Preference and Adherence. Volume 15. 775–783. 6 indexed citations
16.
Zhu, Shuai, Lei Xi, Dongbo Xu, et al.. (2021). Use of crizotinib as neoadjuvant therapy for non‐small cell lung cancers patient with ROS1 rearrangement: A case report. Thoracic Cancer. 12(20). 2815–2818. 10 indexed citations
17.
Xu, Song, Dian Ren, Ming Dong, et al.. (2020). Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data. Cancer Medicine. 9(20). 7686–7694. 12 indexed citations
18.
Wei, Sen, Renwang Liu, Bo Zhang, et al.. (2020). Outcomes of lobectomy on pulmonary function for early stage non‐small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD). Thoracic Cancer. 11(7). 1784–1789. 16 indexed citations
19.
Yang, Fan, Song Xu, Renwang Liu, et al.. (2018). The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing. OncoTargets and Therapy. Volume 11. 919–932. 5 indexed citations
20.
Hu, Jinsong, Els Van Valckenborgh, Dehui Xu, et al.. (2013). Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro. Molecular Cancer Therapeutics. 12(9). 1763–1773. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flavio Fazioli Breakdown of academic impact, for papers by Dominic Fong Breakdown of academic impact, for papers by Michaela Nathrath Breakdown of academic impact, for papers by Julian Schardt Breakdown of academic impact, for papers by Natacha Entz‐Werlé Breakdown of academic impact, for papers by Rajesh R. Singh Breakdown of academic impact, for papers by Joan Somja Breakdown of academic impact, for papers by Robert Königsberg Breakdown of academic impact, for papers by Susanna Cappia Breakdown of academic impact, for papers by Karl Götte
Rankless by CCL
2026